Regeneron Pharmaceuticals, Inc.

Clearstead Advisors, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

1,108

Value ($000)

856

Weight

0.0%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	856	0.0%	1,108	12/31/2025
2025 Q3	11/10/2025	498	0.0%	885	9/30/2025
2025 Q2	8/8/2025	230	0.0%	439	6/30/2025
2025 Q1	5/13/2025	349	0.0%	551	3/31/2025
2024 Q4	2/10/2025	363	0.0%	510	12/31/2024
2024 Q3	11/13/2024	506	0.0%	481	9/30/2024
2024 Q2	8/12/2024	530	0.0%	504	6/30/2024
2024 Q1	5/14/2024	423	0.0%	433	3/31/2024
2023 Q4	2/12/2024	421	0.0%	479	12/31/2023
2023 Q3	11/7/2023	380	0.0%	462	9/30/2023
2023 Q2	8/7/2023	344	0.0%	479	6/30/2023
2023 Q1	5/9/2023	373	0.0%	454	3/31/2023
2022 Q4	2/14/2023	235	0.0%	326	12/31/2022
2022 Q3	11/15/2022	206	0.0%	299	9/30/2022
2022 Q2	8/12/2022	177	0.0%	299	6/30/2022
2022 Q1	5/4/2022	209	0.0%	299	3/31/2022
2021 Q4	2/14/2022	189	0.0%	299	12/31/2021
2021 Q3	11/12/2021	50	0.0%	82	9/30/2021
2021 Q2	8/12/2021	46	0.0%	82	6/30/2021
2021 Q1	5/14/2021	49	0.0%	104	3/31/2021
2020 Q4	2/11/2021	33	0.0%	69	12/31/2020
2020 Q3	11/12/2020	38	0.0%	67	9/30/2020
2020 Q2	8/11/2020	32	0.0%	52	6/30/2020
2020 Q1	5/14/2020	25	0.0%	52	3/31/2020